Brookline Capital Management issued their Q3 2025 earnings estimates for shares of CRISPR Therapeutics in a report released ...

We recently published a list of Shares of 10 Firms Soar on Friday. In this article, we are going to take a look at where ...

Citi analysts adjusted their outlook on CRISPR Therapeutics (NASDAQ:CRSP) stock, reducing the price target to $82 from $89 while maintaining a Buy rating. The stock, which has shown significant ...

An innovative study reveals that HRT coordinates the hatching of fish embryos, determining the critical moment for their ...

Applied DNA Sciences, Inc. (NASDAQ: APDN) Q1 2025 Earnings Call Transcript February 13, 2025 Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $ ...

Sequencing bacterial genomes allows scientists to study bacterial diversity, immunity, and the human microbiome, but it ...

None of the three big indexes marked a feat worth hailing on Friday: the S&P 500 closed flat, the Dow Jones Industrial Average finished slightly lower, and the Nasdaq Composite ticked a smidge higher.

Wolfe Research cut shares of Fluence Energy (NASDAQ:FLNC – Free Report) from an outperform rating to a peer perform rating in ...